APA

Raschi E., Salvo F., La Placa M., Poluzzi E. & De Ponti F. (20210514). Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction. : Journal of the European Academy of Dermatology and Venereology : JEADV.

Chicago

Raschi E, Salvo F, La Placa M, Poluzzi E and De Ponti F. 20210514. Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction. : Journal of the European Academy of Dermatology and Venereology : JEADV.

Harvard

Raschi E., Salvo F., La Placa M., Poluzzi E. and De Ponti F. (20210514). Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction. : Journal of the European Academy of Dermatology and Venereology : JEADV.

MLA

Raschi E, Salvo F, La Placa M, Poluzzi E and De Ponti F. Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction. : Journal of the European Academy of Dermatology and Venereology : JEADV. 20210514.